The research from UVA’s Jogender Tushir-Singh, PhD, explains why the antibody … But when tested in phase-II human clinical trials, these antibodies …, The research from UVA’s Jogender Tushir-Singh, PhD, explains why the antibody … But when tested in phase-II human clinical trials, these antibodies …, Read More